Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Animal Genetics
|
June 26, 2001
COM184: a polymorphic microsatellite marker for CKB on chicken chromosome 5
M Clendenning, N Bumstead
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 24, 2001
Topiramate and hepatotoxicity
R J Doan, M Clendenning
Clinical Genetics
|
May 15, 2012
Recurrent and founder mutations in the PMS2 gene
J Tomsic, L Senter, S Liyanarachchi, et al.
Journal of Medical Genetics
|
January 8, 2008
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome
M Clendenning, L Senter, H Hampel, et al.
Clinical Genetics
|
September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression
M Clendenning, F A Macrae, M D Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, M J Mason, F A Sinicrope, et al.
Gut
|
August 5, 2010
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease
M O Woods, H B Younghusband, P S Parfrey, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Animal Genetics
|
June 26, 2001
COM184: a polymorphic microsatellite marker for CKB on chicken chromosome 5
M Clendenning, N Bumstead
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 24, 2001
Topiramate and hepatotoxicity
R J Doan, M Clendenning
Clinical Genetics
|
May 15, 2012
Recurrent and founder mutations in the PMS2 gene
J Tomsic, L Senter, S Liyanarachchi, et al.
Journal of Medical Genetics
|
January 8, 2008
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome
M Clendenning, L Senter, H Hampel, et al.
Clinical Genetics
|
September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression
M Clendenning, F A Macrae, M D Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, M J Mason, F A Sinicrope, et al.
Gut
|
August 5, 2010
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease
M O Woods, H B Younghusband, P S Parfrey, et al.
Page
of 1